1. Home
  2. Stock quotes
  3. Aerpio Pharmaceuticals, Inc.
  4. Financial Statements
  5. Income Statement
  6. General and Administrative Expenses
Aerpio Pharmaceuticals, Inc. logo
Aerpio Pharmaceuticals, Inc. ARPO

Aerpio Pharmaceuticals, Inc. General and Administrative Expenses 2011-2026 | ARPO

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.
What these expenses include
  • Salaries of administrative staff (executives, HR, accountants, legal personnel)
  • Office rent and utilities
  • Office equipment and IT infrastructure
  • Professional services (auditors, lawyers, consultants)
  • Insurance
  • General administrative travel and representation expenses
What the metric indicates
  • Cost control
    A high level of such expenses may indicate inefficient management or an overly complex structure
  • Profitability
    Reducing administrative expenses while maintaining stable revenue increases operating profit
  • Comparative analysis
    Investors can compare this metric as a percentage of revenue among companies in the same industry
  • Business flexibility
    Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses Aerpio Pharmaceuticals, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
8.76 M 9.76 M 13.5 M 9.24 M 29.5 K 23 K 22.8 K 22.4 K 23.6 K 20.5 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
13.5 M 20.5 K 4.14 M

General and Administrative Expenses of other stocks in the Biotechnology industry

Issuer General and Administrative Expenses Price % 24h Market Cap Country
Precigen Precigen
PGEN
 		70.1 M $ 3.1 -0.96 % $ 758 M usaUSA
MorphoSys AG MorphoSys AG
MOR
 		78.3 M - 2.43 % $ 254 M germanyGermany
ARCA biopharma ARCA biopharma
ABIO
 		13.1 M - 1052.0 % $ 415 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		5.92 M - 5.93 % $ 314 M canadaCanada
Akero Therapeutics Akero Therapeutics
AKRO
 		37.9 M - - $ 3.67 B usaUSA
Akouos Akouos
AKUS
 		22.2 M - 0.23 % $ 488 M usaUSA
I-Mab I-Mab
IMAB
 		900 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		1.4 B - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
 		16.2 M - 2.54 % $ 160 B franceFrance
Albireo Pharma Albireo Pharma
ALBO
 		69.6 M - -0.23 % $ 916 M usaUSA
Biophytis SA Biophytis SA
BPTS
 		7.15 M - -13.47 % $ 169 M franceFrance
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
 		160 M $ 220.9 2.49 % $ 5 B danmarkDanmark
Aileron Therapeutics Aileron Therapeutics
ALRN
 		13.9 M - 10.36 % $ 9.8 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		4.95 M - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		4.66 M - -1.52 % $ 24.7 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		17 M - - $ 26.5 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
 		85.9 M $ 19.57 1.77 % $ 915 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
 		11 M - -10.17 % $ 12.2 K usaUSA
Aptinyx Aptinyx
APTX
 		19.8 M - -39.0 % $ 4.57 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
 		89.7 M - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
 		7.17 M - 4.01 % $ 150 M canadaCanada
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		25.8 M - - - russiaRussia
Adverum Biotechnologies Adverum Biotechnologies
ADVM
 		63.1 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
 		12.7 M - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
 		12.2 M - -9.65 % $ 45.9 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		1.53 M - - $ 7.46 M israelIsrael
Avenue Therapeutics Avenue Therapeutics
ATXI
 		4.64 M - -52.27 % $ 4.45 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
 		46.7 M $ 1.33 0.76 % $ 339 M britainBritain
Atreca Atreca
BCEL
 		31.5 M - -11.76 % $ 5.79 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		2.08 B - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
 		166 M - - $ 546 M usaUSA
ProQR Therapeutics N.V. ProQR Therapeutics N.V.
PRQR
 		17.4 M $ 1.58 6.04 % $ 99.5 M niderlandNiderland
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		106 M - -4.8 % $ 255 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
 		27.8 M - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
 		78.9 M - - $ 3.74 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		47.9 M - - $ 1.01 B usaUSA
Avid Bioservices Avid Bioservices
CDMO
 		26 M - - $ 789 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		100 M - - $ 867 M germanyGermany
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
 		6.02 M - -74.18 % $ 955 K usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
 		15.2 M $ 8.31 1.59 % $ 111 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
 		73.5 M $ 47.09 1.42 % $ 4.23 B schweizSchweiz
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
 		15.9 M $ 4.53 5.1 % $ 868 M canadaCanada
AIkido Pharma AIkido Pharma
AIKI
 		29.7 M - 1.93 % $ 17.4 M usaUSA
Allakos Allakos
ALLK
 		45.1 M - - $ 28.6 M usaUSA
Brickell Biotech Brickell Biotech
BBI
 		11.2 M - -5.38 % $ 6.06 M usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
 		29.8 M $ 4.22 -0.47 % $ 582 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
 		12.7 M - 3.16 % $ 1.9 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
 		20.9 M - -10.95 % $ 876 K usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
 		18 M - - $ 2.17 B usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
 		5.39 M - -5.98 % $ 34.1 M usaUSA